Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 5Lymphoma 4Neuroblastoma 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Disease 1Adenocarcinoma of Lung 1

Interventions

Doxorubicin 26Bleomycin 24Vinblastine 21Dacarbazine 20Vincristine 18Cyclophosphamide 16Radiotherapy 14Etoposide 13Prednisone 12Filgrastim 11ABVD protocol 10Procarbazine 8Peripheral Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Brentuximab Vedotin 6pegfilgrastim 5Methotrexate 5Dexamethasone 5Cytarabine 5Cyclosporine 5Prednisolone 4Mycophenolic Acid 4Mechlorethamine 4Cyclosporins 4Cisplatin 4Whole-Body Irradiation 3Vinorelbine 3Radiation 3Ifosfamide 3Epoetin Alfa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hodgkin Disease × Vindesine × Clear all
NCT00920153 2016-09-16

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

French Innovative Leukemia Organisation

Phase 3 Terminated
442 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡